Company: EHSI
Filing Date: 2025-09-29
Form Type: DEF 14A
Source: 0001437749-25-030001
Chunk: 28

Company: Elite Health Systems Inc.
Filing Date: 2025-09-29
Form: DEF 14A
Chunk 28
---
 $                                              | 188,000 |     | $                                       | 188,000 |     | $                                              |       - |     | $                                       |       - |     |                                                              | NA |     |                                                       | NA |     | $                                                      | 347.83 |     | $                    | (127   | ) |

| (1) | Alan Gold, our former President and Chairman of the Board is Principal Executive Officer (“PEO”) #1 and was our PEO during the fiscal 2022 through July 2024. Dr. Prasad Jeereddi, our current CEO and Chairman of the Board is PEO #2 and was our PEO from July 2024 through the end of the year. Compensation for our PEOs reflects the amounts of total compensation reported in the “Total column of the “Summary Compensation Table” for Alan Gold and Dr. Jeereddi for the years shown in the table. |
| (2) | The dollar amounts reported represent the amount of “compensation actually paid”, as computed in accordance with SEC rules. The dollar amounts do not reflect the actual amounts of compensation paid to the Company’s CEO during the applicable year.                                                                                                                                                                                                                                                     |
| (3) | There were no non-PEOs during the periods presented.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| (4) | Total Shareholder Return is cumulative for the measurement periods beginning on December 31, 2021, and ending on December 31 of each of 2024, 2023 and 2022, respectively, calculated in accordance with Item 201(e) of Regulation S-K.                                                                                                                                                                                                                                                                    |
| (5) | Reflects “Net Income (Loss)”, in thousands, as reported in the Company’s Consolidated Statements of Operations included in the Company’s Annual Reports on Form 10-K for the years ended December 31, 2024, December 31, 2023 and December 31, 2022.                                                                                                                                                                                                                                                       |

Pay Versus Performance Narrative Disclosure

In accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented in the Pay versus Performance table on CAP and each of total shareholder return (“TSR”) and net loss.

We do not utilize TSR and net loss in our executive compensation program and due to limited resources paid our PEO’s a base salary or stock compensation in lieu of cash with no option grants, bonus or other incentives. However, we expect to utilize performance measures to align executive